Clinical trials
Observational Metabolic Syndrome trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 6 |
| Recruiting | 5 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federico II University | 4 |
| AstraZeneca | 3 |
| University of Roma La Sapienza | 3 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| University of Bari | 2 |
| Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 1 |
| Aziende Chimiche Riunite Angelini Francesco S.p.A | 1 |
| Buzzi Children's Hospital | 1 |
| Comune di Napoli | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 31 |
| Obesity | 9 |
| Cardiovascular Diseases | 5 |
| Hypertension | 4 |
| Overweight | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Atherosclerosis | 2 |
| Fatty Liver | 2 |
| Insulin Resistance | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.